Nederlandse Vereniging voor Hepatologie

Proefschriften

Van alle proefschriften is een digitale samenvatting beschikbaar die u hieronder kunt bekijken.

Het is mogelijk om proefschriftsponsoring aan te vragen. Meer informatie hierover vindt u hier.

Biomarkers for the Risk Stratification and Detection of Early-Stage Hepatocellular Carcinoma

05-09-2025 S.Fu

Lees proefschriftsamenvatting »

Extracellular Vesicles: Key Mediators of Intercellular Communication between Liver Cells

26-06-2025 J. Wang

Lees proefschriftsamenvatting »

Exploring novel therapies for cholestatic liver disease in ‘humanized’ mouse models

21-05-2025 E. Verkade

Lees proefschriftsamenvatting »

Gut-Liver crosstalk: a human perspective of the bile salt FXR-FGF19 regulatory axis in intestinal and hepatobiliary disorders

26-11-2024 K.V.K. Koelfat

Lees proefschriftsamenvatting »

Exploring the role of B cells in chronic hepatitis B virus infections

11-02-2025 Z. Osmani

Lees proefschriftsamenvatting »

Exploring therapeutic targets for Glycogen Storeage Disease type 1 by modulating signal transduction pathways in hepatic in vivo and ex vivo models

25-09-2024 K. Alagere Krishnamurthy

Lees proefschriftsamenvatting »

The impact of endosomal protein sorting in lipid metabolism and liver development

19-06-2024 D.Y. Vos

Lees proefschriftsamenvatting »

Bile acid metabolism in health and disease

27-06-2024 H.D. de Vries

Lees proefschriftsamenvatting »

Risk factors and therapeutic interventions for decompensated cirrhosis affecting the gut-liver-brain axis

27-06-2024 K. de Wit

Lees proefschriftsamenvatting »

Cholangiocellular defense mechanisms in IgG4-related cholangitis: Role of autoantigens and autoantibodies

22-05-2024 R.H.J. Kersten

Lees proefschriftsamenvatting »

Optimizing drug therapy in liver transplantation – for better patient outcomes

05-06-2024 M.B. Mulder

Lees proefschriftsamenvatting »

Therapeutic and prognostic aspects of autoimmune hepatitis

08-04-2024 F.F. van den Brand

Lees proefschriftsamenvatting »

Modulating the enterohepatic circulation in cholestatic and metabolic liver diseases therapeutic perspectives

07-02-2024 R.F. Kunst

Lees proefschriftsamenvatting »

Mind the gut in cystic fibrosis: bridging gaps in intestinal and hepatic pathophysiology

10-01-2024 A. Bertolini

Lees proefschriftsamenvatting »

The Modern Day Heracles – Patient-derived Liver Organoids to Model Rare Pediatric Liver Diseases

30-11-2023 V. Lehmann

Lees proefschriftsamenvatting »

Clinical guidance of polycystic liver disease

14-12-2023 T.R.M. Barten

Lees proefschriftsamenvatting »

Bioengineering hepatic organoids – Development of an alternative model for liver toxicity

14-12-2023 M.C. Bouwmeester

Lees proefschriftsamenvatting »

Human Liver Tissue Engineering – From Organoids to Tissues

14-11-2023 S. Ye

Lees proefschriftsamenvatting »

Towards a functional cure for chronic hepatitis B

30-06-2023 R. Erken

Lees proefschriftsamenvatting »

Novel regulators of hepatic energy metablism

8-11-2023 R.C. Verzijl

Lees proefschriftsamenvatting »

Nieuws

Nederlandse Vereniging voor Hepatologie

Proefschriften

Biomarkers for the Risk Stratification and Detection of Early-Stage Hepatocellular Carcinoma

Extracellular Vesicles: Key Mediators of Intercellular Communication between Liver Cells

Exploring novel therapies for cholestatic liver disease in ‘humanized’ mouse models

Gut-Liver crosstalk: a human perspective of the bile salt FXR-FGF19 regulatory axis in intestinal and hepatobiliary disorders

Exploring the role of B cells in chronic hepatitis B virus infections

Exploring therapeutic targets for Glycogen Storeage Disease type 1 by modulating signal transduction pathways in hepatic in vivo and ex vivo models

The impact of endosomal protein sorting in lipid metabolism and liver development

Bile acid metabolism in health and disease

Risk factors and therapeutic interventions for decompensated cirrhosis affecting the gut-liver-brain axis

Cholangiocellular defense mechanisms in IgG4-related cholangitis: Role of autoantigens and autoantibodies

Optimizing drug therapy in liver transplantation – for better patient outcomes

Therapeutic and prognostic aspects of autoimmune hepatitis

Modulating the enterohepatic circulation in cholestatic and metabolic liver diseases therapeutic perspectives

Mind the gut in cystic fibrosis: bridging gaps in intestinal and hepatic pathophysiology

The Modern Day Heracles – Patient-derived Liver Organoids to Model Rare Pediatric Liver Diseases

Clinical guidance of polycystic liver disease

Bioengineering hepatic organoids – Development of an alternative model for liver toxicity

Human Liver Tissue Engineering – From Organoids to Tissues

Towards a functional cure for chronic hepatitis B

Novel regulators of hepatic energy metablism

Nieuws

Abstract submission DLR2026 open!

Uitreiking Distinguished Hepatology Award

EASL HCC Consensus Conference – 6 mei a.s.

Oratie M.J. (Minneke) Coenraad

LEVER

Informatie voor patiënten